IP Library Granted Patent US 8,551,067
Granted Patent B2
US 8,551,067 · App. 12/112,490 · Granted Oct 8, 2013

Needleless additive control valve

Inventors: Freddy Zinger (Ra'anana, IL); Igor Denenburg (Beberi, LV)
Assignee: Medimop Medical Projects Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,551,067
App. No.
12/112,490
Granted
Oct 8, 2013
Kind
B2
Abstract

A needleless additive control valve for use with a fluid container containing an infusion liquid and having an intravenous (IV) port for administrating the infusion liquid, and an additive transfer device containing a liquid additive and having a male connector for administrating the liquid additive. The needleless additive control valve includes a trifurcated connector body having an IV spike for sealing insertion into the IV port, an outlet port, and a needleless additive port with a female connector for sealingly receiving the additive transfer device's male connector wherein the IV spike, the outlet port and the needleless additive port are in 3 way direct and continuous fluid communication thereby enabling the additive transfer device's liquid additive to be either mixed with the infusion liquid or directly administered to a patient.

Claims (4)

1. A needleless additive control valve for use with a fluid container containing an infusion liquid and having an intravenous (IV) port for administrating the infusion liquid,

the needleless additive control valve comprising a trifurcated connector body having an IV spike with a spiked end for sealing insertion into the IV port, an outlet port fitted with a substitute IV port having a sealing membrane and being configured to sealingly receive a second IV spike for connection to an administration line, the sealing membrane being opened by insertion of the second IV spike into the substitute IV port, and a needleless additive port with a female connector alternately sealingly receiving a male connector of both a needleless syringe containing a liquid additive and a vial adapter connected to a vial containing a medicament additive, the needleless additive port being configured to receive a screw threaded male connector and including (i) an exposed needleless access surface capable of being sterilized for multiple sterile sealing insertions of the male connector therethrough and (ii) a self-sealing access valve urged from a normally closed condition to an open condition on a sealing insertion of a male connector therein;

a first lumen extends between the IV spike and the outlet port within the connector body; and

a second lumen extends from the needleless additive port and intersects with the first lumen within the connector body to be in fluid communication therewith such that said IV spike, said outlet port and said needleless additive port are in 3 way direct and continuous bi-directional fluid communication, thereby enabling the liquid additive of the needleless syringe and/or the medicament additive of the vial to be either mixed with the infusion liquid or directly administered to a patient.

Assignments (2)
CHANGE OF NAME Recorded May 3, 2018
From: MEDIMOP MEDICAL PROJECTS LTD
To: WEST PHARMA SERVICES IL, LTD.
Reel/Frame 046069/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2008
From: ZINGER, FREDDY; DENENBURG, IGOR
To: MEDIMOP MEDICAL PROJECTS LTD.
Reel/Frame 021148/0462 →
Priority Claims (1)
IL 171662 · Oct 30, 2005 · national
Continuity (2)
Continuation In Part PCTIL2006001228 · Oct 26, 2006
Related Publication 20080262465A1 · Oct 23, 2008